🔗 Permalink

Inventor profile of:

Nan Li

City:

Laurel, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by Nan Li

The entities that hold a legal rights for patent applications filed by inventor Li Nan:

The USA, as represented by the Secretary, Department of Health and Human Services 10 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 5 Bethesda, MD United States
EUREKA THERAPEUTICS, INC. 1 Emeryville, CA United States
The United States of America,as represented by the Secretary,Department of Health and Human Services 1 Bethesda, MD United States

Recent patent applications by Li Nan

Nan Li from Laurel, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250281538A1

Human necessities

COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS

#2 | 2025-05-08

US20250144214A1

Human necessities

CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF

#3 | 2025-01-16

US20250017962A1

Human necessities

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF

#4 | 2024-09-12

US20240301084A1

Chemistry; metallurgy

HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF

#5 | 2023-12-21

US20230406953A1

Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS

#6 | 2023-10-26

US20230340146A1

Chemistry; metallurgy

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS

#7 | 2022-03-31

US20220098323A1

Chemistry; metallurgy

High affinity monoclonal antibodies targeting glypican-1 and methods of use

#8 | 2022-03-03

US20220064324A1

Chemistry; metallurgy

Cross species single domain antibodies targeting mesothelin for treating solid tumors

#9 | 2021-12-02

US20210371542A1

Chemistry; metallurgy

Chimeric antigen receptors targeting glypican-3 or mesothelin

#10 | 2021-09-23

US20210292428A1

Chemistry; metallurgy

High affinity monoclonal antibodies targeting glypican-2 and uses thereof

#11 | 2020-07-09

US20200216558A1

Chemistry; metallurgy

Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

InventorID:

2787385 ⎘